OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Sawyers on the Negative Results of the IMbassador250 Trial in mCRPC

April 30th 2020

Charles L. Sawyers, MD, discusses the negative results on the IMbassador250 trial in metastatic castration-resistant prostate cancer.

Dr. Chang on Efforts to Improve Quality of Life in Prostate Cancer

April 30th 2020

Sam S. Chang, MD, MBA, discusses the importance of quality of life in prostate cancer.

Dr. Armstrong on the utility of PARP Inhibitors in Mutated Prostate Cancer

April 30th 2020

Andrew J. Armstrong, MD, discusses the utility of PARP inhibitors in mutated prostate cancer.

Dr. Fendler on Impact of 68Ga-PSMA-11 PET on Prostate Cancer Management

April 29th 2020

Wolfgang Fendler, MD, discusses the utility and pending FDA approval of 68Ga-PSMA-11 PET in prostate cancer.

Dr. Lee on Choosing Among Antiandrogens in Nonmetastatic CRPC

April 29th 2020

Richard (Rick) JaeBong Lee, MD, PhD, discusses choosing among the antidrogens available in the treatment of patients with nonmetastatic castration-resistant prostate cancer.

Dr. Beltran on the Limitations of Tissue Biopsies Versus Liquid Biopsies in CRPC-NE

April 29th 2020

Himisha Beltran, MD, discusses the limitations of tissue biopsies versus liquid biopsies in castration-resistant neuroendocrine prostate cancer.

Dr. Agarwal on the Tolerability of Apalutamide in mCSPC

April 29th 2020

Neeraj Agarwal, MD, discusses the tolerability of apalutamide in metastatic castration-sensitive prostate cancer.

Dr. Kudchadkar on the Biological Differences Between Ocular and Cutaneous Melanoma

April 29th 2020

Ragini R. Kudchadkar, MD, discusses the biological differences between ocular melanoma and cutaneous melanoma.

Dr. Daver on Stem Cell Transplant Considerations in Hematologic Malignancies in Light of COVID-19

April 29th 2020

Naval G. Daver, MD, discusses the impact of COVID-19 on stem cell transplant for patients with hematologic malignancies and other measures put into place to prevent patients from infection.

Dr. Ferris on a Trial Testing ADU-S100/MIW815/Pembrolizumab in Head and Neck Cancer

April 28th 2020

Robert L. Ferris, MD, PhD, director of University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Hillman Professor of Oncology, associate vice chancellor for cancer research, professor of otolaryngology, immunology, and radiation oncology, co-director, Tumor Microenvironment Center, UPMC Hillman Cancer Center, discusses a clinical trial testing ADU-S100/MIW815 plus pembrolizumab (Keytruda) in patients with head and neck cancer.

Dr. Mamdani on the Need for Novel Therapies in Locally Advanced Esophageal/GEJ Adenocarcinoma

April 28th 2020

Hirva Mamdani, MD, discusses the need to develop novel therapies in locally advanced esophageal and gastroesophageal junction adenocarcinoma.

Dr. Lewin on the Addition of HIPEC to Interval Cytoreductive Surgery in Ovarian Cancer

April 28th 2020

Sharyn Lewin, MD, FACS, discusses the utility of hyperthermic intraperitoneal chemotherapy in newly diagnosed advanced-stage ovarian cancer.

Dr. Shinohara on Radiation Therapy Considerations in Prostate Cancer

April 28th 2020

Eric Shinohara, MD, MSCI, discusses radiation therapy considerations for patients with prostate cancer.

Dr. Bradley on the Utility of Ruxolitinib in Myelofibrosis and Polycythemia Vera

April 28th 2020

Terrence J. Bradley, MD, discusses the utility of ruxolitinib (Jakafi) in myelofibrosis and polycythemia vera.

Dr. Fleur-Lominy on the Current Sequencing Strategy in MPNs

April 28th 2020

Shella Saint Fleur-Lominy, MD, PhD, discusses the current sequencing strategy in the treatment of patients with myeloproliferative neiplasms.

Dr. Muss on the Impact of COVID-19 on Elderly Patients With Breast Cancer

April 27th 2020

Hyman B. Muss, MD, sheds light on how the COVID-19 pandemic is impacting elderly patients with breast cancer and explains why geriatric patients are at a heightened risk of developing severe complications from the virus.

Dr. Parker on the Optimal Timing of Salvage Therapy in Prostate Cancer

April 27th 2020

Chris Parker, MD, discusses the optimal timing of salvage radiotherapy for men with prostate cancer.

Dr. Concepcion on Current Testing Patterns in Urology Practices

April 25th 2020

Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses current testing patterns in urology practices.

Dr. Mohler on Recommendations for Genetic Testing in Prostate Cancer

April 25th 2020

James L. Mohler, MD, professor of oncology, associate director, and senior vice president of Translational Research, chief of Inter-Institutional Academics at Roswell Park Comprehensive Cancer Center, discusses recommendations for performing genetic testing in prostate cancer.

Dr. McKay on Evaluating Radium-223 in HRD-Mutant mCRPC

April 25th 2020

Rana R. McKay, MD, assistant professor of medicine and medical oncologist at the University of California, San Diego, discusses planned research in which investigators will evaluate the use of radium-223 dichloride (Xofigo) in patients with homologous recombination deficiency (HRD)-mutant metastatic castration-resistant prostate cancer (mCRPC).